EverSource Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4K | Buy |
853
+781
| +1,085% | +$18.7K | ﹤0.01% | 2261 |
|
|
2025
Q1 | $1.79K | Buy |
72
+24
| +50% | +$596 | ﹤0.01% | 2976 |
|
|
2024
Q4 | $904 | Buy |
+48
| New | +$904 | ﹤0.01% | 3002 |
|
|
2024
Q1 | – | Sell |
-247
| Closed | -$8.33K | – | 2970 |
|
|
2023
Q4 | $8.33K | Buy |
+247
| New | +$8.33K | ﹤0.01% | 1648 |
|
|
2023
Q2 | – | Sell |
-259
| Closed | -$10.6K | – | 2586 |
|
|
2023
Q1 | $10.6K | Buy |
+259
| New | +$10.6K | ﹤0.01% | 1326 |
|
|
2022
Q4 | – | Sell |
-128
| Closed | -$7K | – | 2399 |
|
|
2022
Q3 | $7K | Buy |
128
+107
| +510% | +$5.85K | ﹤0.01% | 1249 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 1659 |
|
|
2022
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 1561 |
|
|
2021
Q4 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 1717 |
|